|
|
||||||||
UCLA Schools of Medicine (Drs. Miller, Satz, and Van Gorp) and Public Health (Dr. Visscher), Los Angeles, CA; The Johns Hopkins Medical Institutions (Drs. Selnes and McArthur, and A.M. Machado), Baltimore, MD; University of Pittsburgh (Dr. Becker), Pittsburgh, PA; and Northwestern University Medical School (Drs. Cohen and Sheridan), Chicago, IL.
We administered a battery of standardized neuropsychological measures to assess cognitive functions in a group of 769 HIV-1 seronagative, 727 asymptomatic HIV-1 seropositive (CDC Groups 2 and 3), and 84 symptomatic HIV-1 seropositive (CDC Group 4) homosexual/bisexual men enrolled in the Multicenter AIDS Cohort Study (MACS). Measures included tests of attention, memory, and psychomotor speed. Comparison of group means revealed significant differences in performance between HIV-1 seropositive and symptomatic HIV-1 seropositive subjects on measures of memory and on measures with strong motor and psychomotor timed components. These findings support the sensitivity of these neuropsychological instruments for detecting cognitive changes that may be related to HIV-1, and are consistent with other reports of neuropsychological abnormalities in symptomatic HIV-1-infected individuals. Asymptomatic seroropositive men, on the other hand, did not differ significantly from seronegative subjects on any of the neuropsychological measures. Only 5.5% of the asymptomatic HIV-1 seropositive men showed abnormal performance on individual tests. This proportion did not differ significantly from that of seronegative controls. Further, among asymptomatic seropositive subjects, we found no statistically significant differences as a function of duration of HIV infection or level of immune system functioning. Thus, results from this study support the hypothesis that the frequency of neuropsychological abnormalities in asymptomatic HIV-1-infected homosexual men is low, and not statistically different from that of seronegative controls.
Address correspondence and reprint requests to Dr. Eric N. Miller, UCLA Neuropsychiatric Institute, Neuropsychology, Room C8-747 NPI,760 Westwood Plaza, Los Angeles, CA 90024.
*The Multicenter AIDS Cohort Study Neuropsychologic Working Group consists of the following investigators in addition to the cited authors. Baltimore, The Johns Hopkins Medical InstitutionsJulie H. McArthur, RN, BSN; Tish Nance-Sproson, MHA; Sue Bass, MA; and Alfred Saah, MD, MPH; Chicago, Howard Brown Memorial Clinic-Northwestern University Medical SchoolJoan S. Chmiel, PhD, and John P. Phair, MD; Los Angeles, University of California at Los Angeles Schools of Public Health and MedicineHal Morgenstern, PhD; Marc Nuwer, MD, PhD; Jan Dudley, MPH; and Roger Detels, MD, MS; Pittsburgh, University of Pittsburgh Graduate School of Public Health and School of MedicineCharles R. Rinaldo, Jr, PhD.
Supported by National Institutes of Health contracts N01 AI 32520, AI 72631, AI 72634, AI 32535, and AI 72676, R01 NS 23936, and the OP GCRC 5MO1RR00722.
Received June 30, 1989. Accepted for publication in final form August 29, 1989.
This article has been cited by other articles:
![]() |
M. A. Cole, J. B. Margolick, C. Cox, X. Li, O. A. Selnes, E. M. Martin, J. T. Becker, H. A. Aronow, B. Cohen, N. Sacktor, et al. Longitudinally preserved psychomotor performance in long-term asymptomatic HIV-infected individuals Neurology, December 11, 2007; 69(24): 2213 - 2220. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Schifitto, J. Zhang, S. R. Evans, N. Sacktor, D. Simpson, L. L. Millar, V. L. Hung, E. N. Miller, E. Smith, R. J. Ellis, et al. A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment Neurology, September 25, 2007; 69(13): 1314 - 1321. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Paul, C. T. Yiannoutsos, E. N. Miller, L. Chang, C. M. Marra, G. Schifitto, T. Ernst, E. Singer, T. Richards, G. J. Jarvik, et al. Proton MRS and Neuropsychological Correlates in AIDS Dementia Complex: Evidence of Subcortical Specificity J Neuropsychiatry Clin Neurosci, August 1, 2007; 19(3): 283 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Wong, K. Robertson, N. Nakasujja, R. Skolasky, S. Musisi, E. Katabira, J. C. McArthur, A. Ronald, and N. Sacktor Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa Neurology, January 30, 2007; 68(5): 350 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-J. Wang, L. Chang, N. D. Volkow, F. Telang, J. Logan, T. Ernst, and J. S. Fowler Decreased brain dopaminergic transporters in HIV-associated dementia patients Brain, November 1, 2004; 127(11): 2452 - 2458. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.L. Ryan, S. Morgello, K. Isaacs, M. Naseer, P. Gerits, and the Manhattan HIV Brain Bank Neuropsychiatric impact of hepatitis C on advanced HIV Neurology, March 23, 2004; 62(6): 957 - 962. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Marcotte, R. Deutsch, J. A. McCutchan, D. J. Moore, S. Letendre, R. J. Ellis, M. R. Wallace, R. K. Heaton, and I. Grant Prediction of Incident Neurocognitive Impairment by Plasma HIV RNA and CD4 Levels Early After HIV Seroconversion Arch Neurol, October 1, 2003; 60(10): 1406 - 1412. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Kalechstein, T. F. Newton, and M. Green Methamphetamine Dependence Is Associated With Neurocognitive Impairment in the Initial Phases of Abstinence J Neuropsychiatry Clin Neurosci, May 1, 2003; 15(2): 215 - 220. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.H. Hinkin, S.A. Castellon, R.S. Durvasula, D.J. Hardy, M.N. Lam, K.I. Mason, D. Thrasher, M.B. Goetz, and M. Stefaniak Medication adherence among HIV+ adults: Effects of cognitive dysfunction and regimen complexity Neurology, December 24, 2002; 59(12): 1944 - 1950. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cherner, E. Masliah, R. J. Ellis, T. D. Marcotte, D. J. Moore, I. Grant, and R. K. Heaton Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis Neurology, November 26, 2002; 59(10): 1563 - 1567. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ernst, L. Chang, J. Jovicich, N. Ames, and S. Arnold Abnormal brain activation on functional MRI in cognitively asymptomatic HIV patients Neurology, November 12, 2002; 59(9): 1343 - 1349. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Patel, D. L. Kolson, G. Glosser, I. Matozzo, Y. Ge, J. S. Babb, L. J. Mannon, and R. I. Grossman Correlation between Percentage of Brain Parenchymal Volume and Neurocognitive Performance in HIV-Infected Patients AJNR Am. J. Neuroradiol., April 1, 2002; 23(4): 543 - 549. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chang, O. Speck, E. N. Miller, J. Braun, J. Jovicich, C. Koch, L. Itti, and T. Ernst Neural correlates of attention and working memory deficits in HIV patients Neurology, September 25, 2001; 57(6): 1001 - 1007. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chang, T. Ernst, M. Leonido-Yee, M. Witt, O. Speck, I. Walot, and E. N. Miller Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia Neurology, September 1, 1999; 53(4): 782 - 782. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. Sacktor, R. H. Lyles, R. L. Skolasky, D. E. Anderson, J. C. McArthur, G. McFarlane, O. A. Selnes, J. T. Becker, B. Cohen, J. Wesch, et al. Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men Neurology, May 1, 1999; 52(8): 1640 - 1640. [Abstract] [Full Text] |
||||
![]() |
F. L. Wilkie, K. Goodkin, C. Eisdorfer, D. Feaster, R. Morgan, M. A. Fletcher, N. Blaney, M. Baum, and J. Szapocznik Mild Cognitive Impairment and Risk of Mortality in HIV-1 Infection J Neuropsychiatry Clin Neurosci, May 1, 1998; 10(2): 125 - 132. [Abstract] [Full Text] |
||||
![]() |
F. D. Armstrong, J. F. Seidel, and T. P. Swales Pediatric HIV Infection: A Neuropsychological and Educational Challenge J Learn Disabil, February 1, 1993; 26(2): 92 - 103. [Abstract] [PDF] |
||||
![]() |
E. Murray, D. Rausch, J Lendvay, L. Sharer, and L. Eiden Cognitive and motor impairments associated with SIV infection in rhesus monkeys Science, March 6, 1992; 255(5049): 1246 - 1249. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |